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Abstract
Background: HIV incidence in adolescent girls and young women remains high in sub-Saharan Africa. Progress towards
uptake of HIV prevention methods remains low. Studies of oral pre-exposure prophylaxis (PrEP) have shown that uptake and
adherence may be low due to low-risk perception and ambivalence around using antiretrovirals for prevention. No evidence
exists on whether an interactive intervention aimed at adjusting risk perception and addressing the uncertainty around PrEP
will improve uptake. This pilot research trial aims to provide an initial evaluation of the impact of an interactive digital tablet-
based counselling session, correcting risk perception, and addressing ambiguity around availability, usability,
and effectiveness of PrEP.
Methods/Design: This is a matched-cluster randomized controlled trial which will compare an interactive
tablet-based education intervention against a control with no intervention. The study will be implemented in
eight sites. In each site, two matched clusters of villages will be created. One cluster will be randomly
allocated to intervention. In two sites, a community engagement intervention will also be implemented to
address social obstacles and to increase support from peers, families, and social structures. A total of 1200
HIV-negative young women aged 18–24 years, not on PrEP at baseline, will be eligible. Baseline measures of
endpoints will be gathered in surveys. Follow-up assessment at six months will include biomarkers of PrEP
uptake and surveys.
Discussion: This will be the first randomized controlled trial to determine whether interactive feedback
counselling leads to uptake of HIV prevention methods such as PrEP and reduces risky sexual behavior. If
successful, policymakers could consider such an intervention in school-based education campaigns or as post-
HIV-testing counselling for young people.
Trial registration: Clinicaltrials.gov, NCT03565575. Registered on 21 June 2018.
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Background
HIV incidence remains extremely high in adolescent
girls and young women (AGYW) aged 15–24 years in
sub-Saharan Africa, accounting for one in five new HIV
infections in 2017 despite representing just 10% of the
population [1]. The urgency to reduce HIV incidence
among AGYW is widely recognized. The United Nations
General Assembly adopted a Political Declaration with
the target of < 100,000 new infections in AGYW by 2020
[2]. In Zimbabwe, where 9000 AGYW became newly in-
fected with HIV in 2017, the Zimbabwe National HIV
and AIDS Strategic Plan aims to halve HIV incidence by
2020 [3].
A number of efficacious HIV prevention methods exist
that could reduce HIV incidence for AGYW either dir-
ectly (e.g. pre-exposure prophylaxis [PrEP], condoms,
partner reduction) and indirectly (e.g. male partner re-
duction, voluntary medical male circumcision [VMMC])
but use of these strategies is still low [4]. PrEP, in par-
ticular, can empower individuals with few other personal
prevention options and so has the potential to strongly
reduce HIV incidence among AGYW [5, 6]. However,
PrEP remains largely unavailable in sub-Saharan Africa
and slow progress has been made towards the UNAIDS
2020 target of reaching 3 million people at risk of HIV
with PrEP [5].
Oral PrEP has demonstrated substantial HIV preven-
tion benefits (up to 75% reduction in HIV incidence) in
trials. Qualitative evidence from the VOICE trial indi-
cates that low uptake and adherence may be due to un-
certainty and ambivalence about using antiretrovirals for
prevention and concerns about side effects [7]. In
addition, the FEM-PrEP study found that women under-
estimated their risk of infection and that perceived risk
was associated with greater adherence to PrEP [8]. A key
gap is whether, when counselled about their risk of in-
fection, the local availability, effectiveness, tolerability,
and ease of use of PrEP, AGYW in Zimbabwe will take
up oral PrEP.
Two previous studies have evaluated the impact of dis-
aggregated information on HIV risks. Datta et al. [9]
evaluated the impact of an interactive computer game
on changes in respondents’ (men and women aged 15–
19 years) understanding of the relationship between
HIV-risk and age, and retention of knowledge after three
months. Dupas [10] evaluated a classroom intervention
(women in grade 8) providing disaggregated risk infor-
mation to young women and used teen pregnancies as
an objective proxy for unprotected sex. These studies,
however, did not consider long-term behavior change,
for example, partner reduction or uptake of HIV preven-
tion methods. In the case of Datta and Burns [9], the
sample consisted of university students so may be of
limited generalizability.
The present study makes several innovative contribu-
tions. It tests the usability and acceptability of interactive
learning delivered through tablets in urban and rural
populations in a sub-Saharan African setting. In
addition, it is the first study to evaluate longer-term be-
havior change resulting from interactive feedback-based
learning regarding relative HIV risk. It evaluates the im-
pact of such learning on uptake of PrEP, a relatively new
HIV prevention method in Africa.
The purpose of this study is to pilot test and evaluate
the impact on risk perception and PrEP uptake within
six months in AGYW aged 18–24 years of an interactive
digital tablet-based counselling session, aiming at cor-
recting risk perception and addressing ambiguity around
availability, usability, and effectiveness of PrEP. The
study hypothesizes that correcting misperceptions of
risks of HIV infection and offsetting ambiguity effects
about the availability, usability, and efficacy of PrEP,
through localized, interactive, tablet-based counselling,
will improve risk perception and increase uptake of PrEP
in HIV-negative AGYW without having an adverse effect
on underlying sexual risk behavior.
Methods/Design
Study design
This is a prospectively registered, two-arm matched-
cluster randomized controlled trial (RCT) with single
(outcomes assessor) masking, intention-to-treat analysis,
and six-month follow-up (Fig. 1). The study is being im-
plemented in eight sites in Manicaland Province, east
Zimbabwe. The study will be implemented consecutively
on a site-by-site basis. In each site, two matched clusters
of villages will be created. Clusters will be randomly allo-
cated to intervention or control arm. In each study site,
a census of all households in the study clusters at base-
line will be used to identify AGYW aged 15–24 years
who are resident within the study areas. A detailed indi-
vidual questionnaire will collect information on primary
endpoints, following which provider-initiated HIV test-
ing and counselling will be offered. Individuals identified
as eligible following this stage will be invited to partici-
pate in the intervention.
Intervention participants will play an interactive
digital tablet-based quiz including the following informa-
tion components: (1) risks of HIV infection under differ-
ent scenarios such as between two hypothetical
individuals and with different behaviors; and (2) inter-
active counselling on key facts around PrEP, its usability,
and local availability. Participants will have the option to
sign up for contact by a nurse from the health clinic to
discuss PrEP further and to make an appointment for a
visit. In addition, in two of the eight sites, a community-
engagement intervention using Community Conversa-
tions (CC) [11, 12] will be implemented to address social
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and cultural barriers to taking up PrEP and support the
abovementioned individual-level intervention. No inter-
ventions will be implemented in the control arm.
Participant informed consent and data collection will
be carried out by trained research assistants. HIV testing
will be done by appropriately trained and accredited staff
following the standard procedures and testing algorithm
used in the Zimbabwe Ministry of Health and Child
Care (ZMoHCC) routine provider-initiated testing and
counselling (PITC) services. HIV field test results will be
returned to participants the same day. Participants who
test positive for HIV will receive referral to treatment
services in accordance with national guidelines. Partici-
pants testing negative for HIV will also receive post-test
counselling and, in intervention clusters, will be invited
to participate in the intervention.
Intervention participants will be referred to clinics of-
fering PrEP. When individuals begin PrEP in the form of
Truvada (a fixed combination of Tenofovir-TFV and
Emtricitabine-FTC), adherence to the once-daily intake
of the drug will be monitored using the levels of TFV as
a biomarker [13]. This will give direct quantitative mea-
sures of adherence and will enable appropriate interven-
tions to be implemented to reduce both the risk of sero-
conversion and the risk of developing drug resistance to
the acquired infection. Dried blood spots (DBS) will be
collected from participants six months after initiation of
Truvada-based PrEP.
Statistical analyses will be carried out by researchers
blinded to group allocation. Before enrolment, all partici-
pants will provide written informed consent. All personal
data will be confidential. The study has obtained ethical
approvals from the Medical Research Council of
Zimbabwe (Ref. MRCZ/A/2243), the institutional review
board of the Biomedical Research and Training Institute
in Zimbabwe (Ref. AP140/2017), and the Imperial College
London Research Ethics Committee (Ref. 17IC4160).
Qualitative explorations
Formative qualitative explorations will be embedded into
different stages of the study. Formative consultations
with local stakeholders and a youth advisory board will
Fig. 1 Study design
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provide feedback on the intervention procedures, while
qualitative studies will contextualize study outcomes by
exploring local norms, experiences and perspectives con-
cerning PrEP. Participants for the qualitative studies will
be recruited from settings randomly chosen because of
their rural/urban location and for being subject to both
PrEP and community conversation interventions – allow-
ing a contrast of experiences. Forty AGYW from the two
settings will be invited to participate in either individual
interviews (n = 12), focus group discussions (n = 18), or
participatory photography (n = 10) with the aim of reveal-
ing how they encounter, respond to, and negotiate PrEP
uptake and engagement. The AGYW will be chosen from
the baseline survey by purposeful sampling following the
criteria that they have to be: aged 18–24 years; HIV-
negative; sexually active; considered “at risk” (according to
a WHO risk screening tool); agreed to be contactable; and
volunteered to participate. In addition, AGYW will be
sampled to represent a mix of those who attended and did
not attend PrEP sessions, to explore their reasons and mo-
tivations to participate (or otherwise) in the intervention.
Individual interviews with parents of AGYW (n = 8), inter-
views with HIV prevention service providers (n = 12),
focus groups with community members (n = 6; ~ 36 par-
ticipants), and qualitative studies with 40 young men will
also be conducted to gain insight to the broader social
context of PrEP and AGYW friendly HIV-prevention ser-
vices. The proposed sample sizes are estimates deemed
sufficient to reach theoretical saturation [14].
Study setting
The study is being conducted in Manicaland province in
east Zimbabwe, covering an area of 36,459 km2 (14,077
square miles) and has a population of approximately
1.75 million (2012) (Fig. 2). Six sites enumerated in a
general population cohort survey that ran from 1998 to
2013 [15]—two small towns, two large agricultural es-
tates, and two rural villages—will be included in the
study, together with two new sites in high-density urban
suburbs in Mutare, the provincial capital (Fig. 2a). The
total estimated population size in these areas is 35,760
people.
Existing data show that, in the rural study sites, HIV
prevalence in AGYW (15–24 years) was7.0% (20.6% in
women and men aged 15–54 years) in towns and 2.1%
(11.9% in women and men aged 15–54 years) in villages
in 2012–2013 (Fig. 2b). Figure 2d shows prevalence in-
creases rapidly with age. Prevalence in pregnant women
(aged 15–24 years) in Sakubva, a site not previously in-
cluded in the general population cohort, was 13.4%
among AGYW (14.3% in women and men aged 15–54)
in 2012 [16].
Intervention procedures
At the start of the intervention, research assistants will
explain the intervention to the treatment arm partici-
pants. Participants will be informed that they will be par-
ticipating in an interactive tablet-based counselling quiz.
The sessions will be held in groups of approximately 20
participants.
The session will begin with training on how to use the
tablet and practice questions. Participants will be en-
couraged to ask questions by raising their hands and the
research assistant will answer every question in private.
Figure 3 provides an outline of the intervention proced-
ure. Participants will then play the interactive counsel-
ling intervention. The information is primarily pictorial
and all information is presented in the local language.
The interactive counselling will include the following in-
formation components:
 Interactive communication of the risks of HIV
infection under different scenarios:
• In each round, participants will be presented
with a question asking which one of two
hypothetical individuals was more likely to have
HIV;
 They will also be asked to choose between different
behaviors (e.g. abstinence or condom use) to reduce
the risk of acquiring HIV;
Fig. 2 Study sites and patterns of HIV risk in AGYW in Manicaland, Zimbabwe: (a) study sites by type and location; (b) spatial pattern of HIV
prevalence, 2009–2011; (c) trends in HIV incidence over time, 1998–2013; and (d) HIV prevalence by two-year age group
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 Interactive counselling on key facts around PrEP
including: what is PrEP; who is PrEP for; how is
PrEP taken; potential side-effects; and availability.
In all cases, participants will immediately be provided
with feedback on the accuracy of their choice, the cor-
rect answer, and a reinforcing message such as “HIV
prevalence is higher amongst older men.”
Following insights from behavioral economics, the
study will also implement a non-binding commitment
device to enhance participants’ engagement. In particu-
lar, all individuals will be encouraged to provide their
contact numbers and a preferred time for contact by a
nurse from the health clinic to discuss PrEP further and
make an appointment for a visit.
Participants will also be provided with a PrEP referral
letter that they can present directly at one of the partici-
pating study clinics to begin PrEP. This article adhered to
the Standard Protocol Items: Recommendations for Inter-
ventional Trials (SPIRIT) 2013 checklist (see Additional
file 1 and Fig. 4).
Further procedures for clusters with community-led
interventions
A participatory reflection and action (PRA) approach to
community engagement will be used. The approach of in-
volving local community structures in addressing health
challenges is based on strong theoretical foundations [17,
18] and has been applied successfully in other health pro-
grams [19–21] and to tackle gender-based violence in the
context of HIV [22]. This approach supports critical
thinking and problem solving around key community is-
sues through CCs. CCs involve posing questions and
thinking points to formal community groups or informal
networks around community challenges and about poten-
tial local responses and community resources to tackle
these. In Zimbabwe, CCs have helped to raise community
HIV competence [23]. This study will be the first to ex-
plore whether and how CCs—as a community engage-
ment strategy—can break down community-level barriers
with implications for uptake of PrEP. In these clusters, the
Diocese of Mutare Community Care Programme
(DOMCCP) will initiate and support a process to: (1)
mobilize and work with pre-existing village structures and
local community groups who have demonstrated a com-
mitment to fight HIV [24]; (2) conduct CCs with formal
groups at village level, generating community action plans;
and (3) provide modest funding and technical support to
community groups to implement their planned activities.
A toolkit on CCs for HIV prevention has been developed
to assist the facilitators, standardizing the process and en-
suring that CCs stay focused on HIV prevention strategies
for AGYW and male partners. The toolkit has been de-
signed to complement the PrEP intervention by: (1)
Fig. 3 Intervention procedures
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instigating discussions on HIV risk – cementing the sali-
ence of HIV prevention methods and on social prefer-
ences and biases to use of PrEP; (2) identifying innovative
community-led solutions that help AGYW and young
men overcome social barriers and re-think risk percep-
tions; and (3) developing clear steps for communities to
prevent the spread of HIV, drawing on local knowledge,
resources, and existing local activities. Practically, each CC
will comprise 10–15 people who, in four sessions, will: (1)
share personal experiences; (2) discuss the challenges/
factors preventing AGYW and partners from using HIV
prevention methods; (3) explore how to respond; and (4)
agree on steps to include in action plans and identify the
necessary resources. The community groups will then im-
plement, evaluate, and update their plans.
Inclusion and exclusion criteria
A total of 1200 women will be considered eligible if: (1)
they are aged 18–24 years; (2) they live in the interven-
tion cluster (see below) in one of the eight study sites in
Fig. 4 Timeline of study procedures
Thomas et al. Trials          (2019) 20:668 Page 6 of 9
Manicaland province; and (3) they expect to be resident
there for the duration of the study. Participants will be
excluded if they test positive for HIV at baseline or self-
report taking PrEP at baseline. To avoid indirect disclos-
ure of the status of HIV-positive individuals, a random
sample of 90% of otherwise eligible HIV-negative women
will be selected to participate in the intervention.
Randomization/masking
In each study site, community leaders will first be
contacted and clearance will be sought to carry out
activities. In addition, community meetings will be or-
ganized to introduce the activities before the start of
any procedures. Within each of the eight study sites
(including the two sites with the additional CC inter-
vention component), detailed site maps will be used
to create two matched clusters of villages based on
socioeconomic characteristics and factors such as dis-
tances to trading centers, major roads, and health
centers. Clusters within a site will be randomly allo-
cated to intervention or control using a simple coin
toss process. Thus, all eight sites will contain two
clusters each (intervention and control). Young
women in intervention clusters will receive the inter-
active intervention (and in two sites, CCs will also be
implemented). Young women in the control villages
will receive no intervention and will be followed up
for measurement of outcomes at six months. Partici-
pants will not be masked for the intervention they re-
ceive due to cluster level randomization and the
nature of the intervention. Study interventions and
measurements will occur in separate locations and
time points thus facilitating the blinding of outcomes
assessors.
Primary and secondary outcomes
HIV prevention cascades (HPCs) have been proposed to
facilitate identification of gaps in implementation of pri-
mary HIV prevention methods, understanding of the
reasons for these gaps, and identification and evaluation
of promising interventions to address the gaps [25, 26].
The population of HPCs using existing study data moti-
vated the selection of some of the outcomes for this
study. While no prior measurements were available to
populate a HPC specifically for PrEP, analyses of the
HPC for existing prevention methods among AGYW in
the study population [25, 26] found major gaps in per-
ceptions about personal risk of HIV infection.
The primary outcome for the study will be the propor-
tion of women taking up PrEP within six months mea-
sured via biomarkers of ARV presence from DBS and
triangulated with self-reports and clinic data. The sec-
ondary outcomes will be risk perception measured at
baseline and in a follow-up survey at six months, and
self-reported change in sexual behavior between baseline
and follow-up surveys.
Sample size estimates
It is estimated that a sample size of 600 participants per
arm would be necessary to detect meaningful minimum
effect sizes (around 20%) for the primary endpoint (PrEP
uptake), with 80% power (α = 0.005). Survey data from the
study sites in 2012–2013 were used to calculate mean
cluster size, coefficient of variation in cluster size (0.15 for
women), and the intra-cluster correlation coefficient
(ICC) (0.04 using HIV incidence as the outcome). Baseline
prevalence estimates of endpoint indicators were assumed
to be 10% for PrEP. It was also assumed that 80% of eli-
gible participants consent to participate and that 80% of
these are followed up at six months (mean cluster size of
48). The exploratory nature of the intervention combining
interactive counselling and community engagement
means that we have chosen to use only two clusters for
this intervention as this allows greater power to detect the
effect without the community-level intervention. Never-
theless, in the two sites with the combined intervention,
the study is powered to detect large impacts (effect size
difference = 40%) on the outcome indicators. As a further
consequence, there is not sufficient power to examine the
interaction of the effect sizes with and without the
addition of the community-level intervention.
Statistical analysis
Analysis of the primary outcomes will be done on an
intention-to-treat basis. For each endpoint, a linear regres-
sion will be used to estimate differences in the cluster-
level prevalence of the indicator at follow-up. The inter-
vention and control clusters in the six study sites with
only the digital interactive counselling will be compared in
one analysis. A separate analysis will compare intervention
and control clusters in the two study sites which also in-
clude the community conversations component. Any indi-
cators unbalanced at baseline will be included as
covariates. The Shapiro–Wilk normality test will be used
to test for non-normality of the model residuals, and
standard non-parametric tests (e.g. Mann–Whitney rank-
sum test) will be used in case of non-normality. Effect
sizes will be reported with 95% confidence intervals and
results will be considered significant if P < 0.05. Data will
be analyzed using STATA version 15.
Discussion
This trial will evaluate the impact of an interactive
counselling game on improving perception of HIV
risk and uptake of PrEP among young women aged
18–24 years. The present study will provide reliable
and high-quality estimates of the average treatment
effects because it is a randomized and prospectively
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registered study, it masks the evaluators, and it uses
an intention-to-treat approach. Sample size was calcu-
lated to provide adequate statistical power to identify
possible differences in the study’s primary outcome.
In addition, the six-month follow-up will allow ad-
equate time for participants to present at clinic with
referral letters for PrEP and to evaluate changes in
risky sexual behavior but not be too long to measure
adjustment in risk perception. Findings from this
study will help determine whether interactive feed-
back counselling leads to uptake of HIV prevention
methods such as PrEP and reduces risky sexual be-
havior. If successful, policymakers could consider such
an intervention in school-based education campaigns
or as post-HIV-testing counselling for young people.
This study has limitations. Some participants may
be unable to read information presented as text, al-
though the general literacy level in Zimbabwe is rela-
tively high even in rural areas. Another potential
limitation is the possibility of lower than expected re-
tention rates especially among young women who
may move away due to marriage or for family rea-
sons. Any retention challenges will provide valuable
information in planning for future research and inter-
vention implementation. Other limitations of this
RCT could include recruitment challenges and poten-
tial sampling bias. The eligibility, recruitment, enrol-
ment, and retention will be closely monitored to
overcome such challenges.
To reach and maintain the UNAIDS 90–90-90 goals
and to achieve the Sustainable Development Goal of
ending the AIDS epidemic as a public health threat by
2030, considerable expansions of HIV prevention efforts
are needed. This is especially the case for AGYW who
face a high risk of acquiring a lifelong incurable infection
which threatens their health and wellbeing. However,
while efficacious methods of HIV prevention exist, their
uptake remains limited. This study will generate import-
ant knowledge to inform HIV prevention policies about
the effectiveness of novel interventions to improve HIV
prevention uptake, which are devised in such a way that
they could be easily scaled up (e.g. as an extension to
routine HIV testing and counselling services). These re-
sults will not only be applicable to Zimbabwe but also to
other settings with high HIV prevalence.
Trial status
This trial has been registered on clinicaltrials.gov (identifier:
NCT03565575) on 21st June 2018. https://clinicaltrials.gov/
ct2/show/NCT03565575. Recruitment commenced on 7 July
2018 and is expected to be completed by 31 December 2019.
Follow-up data collection will be completed by 31 August
2020. Protocol version 1.6, 19 April 2019.
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